Multiple adjournments push iSpecimen (NASDAQ: ISPC) 2025 annual meeting to May 8, 2026
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
iSpecimen Inc. is continuing efforts to complete its 2025 Annual Meeting of Stockholders. The meeting was first convened on December 31, 2025, but was repeatedly adjourned on January 23, 2026, February 13, 2026, March 13, 2026 and April 10, 2026 because a quorum was not present. The company now plans to reconvene the Annual Meeting on May 8, 2026 at 9:00 a.m. Eastern Time. The record date for stockholders entitled to vote remains November 3, 2025, and the proposals to be voted on are unchanged from those described in the definitive proxy statement filed on November 21, 2025.
Positive
- None.
Negative
- None.
Insights
Repeated quorum failures show shareholder participation challenges but no proposal changes.
iSpecimen has tried multiple times to hold its 2025 Annual Meeting, adjourning four reconvened sessions because a quorum was not present. This suggests many shareholders have not voted or attended despite ongoing solicitation based on the existing proxy.
The company will try again on May 8, 2026, keeping the November 3, 2025 record date and original proposals described in the November 21, 2025 proxy statement. The situation is administrative but highlights how low retail engagement can delay routine corporate business until sufficient votes are collected.
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
Initial 2025 Annual Meeting date: December 31, 2025
Reconvened meeting dates: Jan 23, Feb 13, Mar 13, Apr 10, 2026
Next reconvened meeting date: May 8, 2026
+2 more
5 metrics
Initial 2025 Annual Meeting date
December 31, 2025
Original convening of 2025 Annual Meeting of Stockholders
Reconvened meeting dates
Jan 23, Feb 13, Mar 13, Apr 10, 2026
Dates when meetings were reconvened without quorum
Next reconvened meeting date
May 8, 2026
Planned reconvening of 2025 Annual Meeting at 9:00 a.m. Eastern
Record date for voting
November 3, 2025
Stockholders entitled to vote at the 2025 Annual Meeting
Proxy statement filing date
November 21, 2025
Date definitive proxy statement describing proposals was filed
Key Terms
Annual Meeting of Stockholders, quorum, definitive proxy statement, record date, +1 more
5 terms
Annual Meeting of Stockholders financial
"iSpecimen Inc. convened its 2025 Annual Meeting of Stockholders"
quorum financial
"Because a quorum was not present, the Company adjourned the Annual Meeting"
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
definitive proxy statement financial
"proposals set forth in the Company’s definitive proxy statement filed"
A Definitive Proxy Statement is a detailed document that a company sends to its shareholders before a big meeting, like voting on important decisions. It explains what's being voted on and gives important information so shareholders can make informed choices. It matters because it helps shareholders understand and participate in key company decisions.
record date financial
"The record date for determination of stockholders entitled to vote"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
Why has iSpecimen (ISPC) not completed its 2025 annual meeting?
iSpecimen has repeatedly adjourned its 2025 Annual Meeting because a quorum was not present on December 31, 2025 and on reconvened dates in January, February, March, and April 2026. Without a quorum, stockholders cannot formally vote on the listed proposals.
When will iSpecimen (ISPC) reconvene its 2025 Annual Meeting of Stockholders?
iSpecimen plans to reconvene its 2025 Annual Meeting of Stockholders on May 8, 2026 at 9:00 a.m. Eastern Time. This new date follows several prior adjournments caused by the failure to achieve a quorum of shares entitled to vote.
What is the record date for voting at iSpecimen’s 2025 annual meeting?
The record date for determining stockholders entitled to vote at iSpecimen’s 2025 Annual Meeting remains November 3, 2025. Only holders of the company’s common stock as of that date are eligible to vote on the meeting’s proposals.
Have iSpecimen’s 2025 annual meeting proposals changed after the adjournments?
No. The company states that no changes have been made to the proposals for the 2025 Annual Meeting. The proposals remain exactly as described in iSpecimen’s definitive proxy statement filed on November 21, 2025 with the Securities and Exchange Commission.
What disclosure did iSpecimen (ISPC) file about its 2025 annual meeting?
iSpecimen filed a Form 8-K under the “Other Events” item explaining that its 2025 Annual Meeting lacked a quorum on multiple dates and was adjourned. The filing also discloses plans to reconvene the meeting on May 8, 2026 using the same proposals.
Which dates did iSpecimen attempt to reconvene its 2025 annual meeting?
iSpecimen reconvened the 2025 Annual Meeting on January 23, 2026, February 13, 2026, March 13, 2026 and April 10, 2026. Each reconvened session was adjourned again because a quorum of stockholders was not present to conduct business.